|
|
眼缺血综合征伴发新生血管性青光眼一例
|
Abstract:
新生血管性青光眼是一种难治性青光眼，常继发于全身疾病或眼部疾病，往往伴有严重视力下降甚至丧失，主要体征是虹膜新生血管，高眼压。本文讲述1例视力、体征治疗后均明显好转的新生血管性青光眼。
Neovascular glaucoma is a kind of refractory glaucoma, often secondary to systemic or ocular dis-eases, accompanied by severe vision loss or even loss, the main signs are iris neovasculation and high intraocular pressure. This article describes a case of neovascular glaucoma, whose visual acuity and physical signs improved significantly after treatment.
| [1] | Senthil, S., Dada, T., Das, T., et al. (2021) Neovascular Glaucoma—A Review. Indian Journal of Ophthalmology, 69, 525-534. https://doi.org/10.4103/ijo.IJO_1591_20 |
| [2] | 覃柳. 新生血管性青光眼发病机制及治疗策略进展[J]. 吉林医学, 2022, 43(1): 245-247. |
| [3] | Mendrinos, E., Machinie, T.G. and Pournaras, C.J. (2010) Ocular Ischemic Syn-drome. Survey of Ophthalmology, 55, 2-34. https://doi.org/10.1016/j.survophthal.2009.02.024 |
| [4] | Sharma, S. and Brown, G.C. (2006) Ocular Ischemic Syndrome. In: Ryan, S.J., Hinton, D.R., Schachat, A.P. and Wilkinson, C.P., Eds., Retina, Vol. 2, Elsevier, Amsterdam, 1491-1502.
https://doi.org/10.1016/B978-0-323-02598-0.50090-2 |
| [5] | Sivalingam, A., Brown, G.C. and Magargal, L.E. (1991) The Ocular Ischemic Syndrome. III. Visual Prognosis and the Effect of Treatment. International Ophthalmology, 15, 15-20. https://doi.org/10.1007/BF00150974 |
| [6] | Terelak-Borys, B., Skonieczna, K. and Grabska-Liberek, I. (2012) Ocular Ischemic Syndrome—A Systematic Review. Medical Science Monitor, 18, RA138-RA144. https://doi.org/10.12659/MSM.883260 |
| [7] | Wang, J.W., Zhou, M.W., Zhang, X., Huang, W.B., Gao, X.B., Wang, W., Chen, S., Zhang, X.Y., Ding, X.Y. and Jonas, J.B. (2015) Short-Term Effect of Intravitreal Ranibizumab on Intraoc-ular Concentrations of Vascular Endothelial Growth Factor-A and Pigment Epithelium-Derived Factor in Neovascular Glaucoma. Clinical & Experimental Ophthalmology, 43, 415-421. https://doi.org/10.1111/ceo.12477 |
| [8] | Urbonavi？iūt？, D., Buteikien？, D. and Janulevi？ien？, I. (2022) A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment. Medicina, 58, Article No. 1870. https://doi.org/10.3390/medicina58121870 |
| [9] | Yu, X.-B., Sun, X.-H., Dahan, E., Guo, W.-Y., Qian, S.-H., Meng, F.-R., Song, Y.-L., Simon, G.J.B. (2007) Increased Levels of Transforming Growth Factor-Beta1 and -Beta2 in the Aqueous Humor of Patients with Neovascular Glaucoma. Ophthalmic Surgery, Lasers and Imaging Retina, 38, 6-14. https://doi.org/10.3928/15428877-20070101-01 |
| [10] | Tripathi, R.C., Borisuth, N.S.C. and Tripathi, B.J. (1992) Detection, Quantification, and Significance of Basic Fibroblast Growth Factor in the Aqueous Humor of Man, Cat, Dog and Pig. Experimental Eye Research, 54, 447-454.
https://doi.org/10.1016/0014-4835(92)90056-X |
| [11] | Kim, Y.H., Sung, M.S. and Park, S.W. (2017) Clinical Fea-tures of Ocular Ischemic Syndrome and Risk Factors for Neovascular Glaucoma. Korean Journal of Ophthalmology, 31, 343-350. https://doi.org/10.3341/kjo.2016.0067 |
| [12] | Spaeth, G.L. (2021) European Glaucoma Society Terminolo-gy and Guidelines for Glaucoma, 5th Edition. British Journal of Ophthalmology, 105, 1-169. https://doi.org/10.1136/bjophthalmol-2021-egsguidelines |
| [13] | Simha, A., Aziz, K., Braganza, A., Abraham, L., Samuel, P. and Lindsley, K.B. (2020) Anti-Vascular Endothelial Growth Factor for Neovascular Glaucoma. Cochrane Database of Systematic Reviews, No. 2, 1465-1858.
https://doi.org/10.1002/14651858.CD007920.pub3 |
| [14] | Bai, L., Wang, Y., Liu, X., et al. (2022) The Optimization of an Anti-VEGF Therapeutic Regimen for Neovascular Glaucoma. Frontiers in Medicine, 8, Article 766032. https://doi.org/10.3389/fmed.2021.766032 |
| [15] | Lazcano-Gomez, G., Soohoo, J.R., Lynch, A., et al. (2017) Neo-vascular Glaucoma: A Retrospective Review from a Tertiary Eye Care Center in Mexico. Journal of Current Glaucoma Practice, 11, 48-51.
https://doi.org/10.5005/jp-journals-10028-1222 |
